Vikas Khemani, president and head of wholesale capital markets at Edelweiss Financial Services, says he’s bullish on the pharma and tech stocks as investors are likely to remain risk averse for at least another year. He thinks that markets will remain tough with intermittent rallies and subsequent sell-offs.